INS and Hyperglycemia: FEN did decrease fasting hyperglycaemia and markedly attenuated glucose intolerance in Leprdb mice (Fig. 2b,c), in association with increased serum insulin (Fig. 2d) and increased pancreatic islet mass (Fig. 2e).